Compare MXL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXL | AORT |
|---|---|---|
| Founded | 2003 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.1B |
| IPO Year | 2010 | 1993 |
| Metric | MXL | AORT |
|---|---|---|
| Price | $17.53 | $45.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $20.25 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 1.2M | 345.5K |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $423,372,000.00 | $422,646,000.00 |
| Revenue This Year | $30.54 | $15.97 |
| Revenue Next Year | $18.23 | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.53 | ★ 9.81 |
| 52 Week Low | $8.35 | $21.97 |
| 52 Week High | $25.73 | $48.25 |
| Indicator | MXL | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 54.22 | 48.90 |
| Support Level | $17.36 | $45.75 |
| Resistance Level | $17.90 | $48.00 |
| Average True Range (ATR) | 0.59 | 1.26 |
| MACD | -0.11 | -0.07 |
| Stochastic Oscillator | 34.97 | 33.59 |
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.